{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:45:15Z","timestamp":1787010315300,"version":"build-2736575974"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1097\/rlu.0b013e31828731f5","type":"journal-article","created":{"date-parts":[[2013,3,12]],"date-time":"2013-03-12T08:31:20Z","timestamp":1363077080000},"page":"516-521","source":"Crossref","is-referenced-by-count":38,"title":["Responsiveness of FDG PET\/CT to Treatment of Patients With Active Chronic Sarcoidosis"],"prefix":"10.1097","volume":"38","author":[{"given":"Dragana P.","family":"Sobic-Saranovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isidora T.","family":"Grozdic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelica","family":"Videnovic-Ivanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violeta","family":"Vucinic-Mihailovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera M.","family":"Artiko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Djordjije Z.","family":"Saranovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smiljana V.","family":"Pavlovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir B.","family":"Obradovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210204","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1378\/chest.10-0188","article-title":"Recent advances in sarcoidosis.","volume":"139","author":"Morgenthau","year":"2011","journal-title":"Chest"},{"key":"R2-5-20210204","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.crad.2010.03.014","article-title":"Multi-technique imaging of sarcoidosis.","volume":"65","author":"Balan","year":"2010","journal-title":"Clin Radiol"},{"key":"R3-5-20210204","first-page":"736","article-title":"Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS), and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee.","volume":"160","author":"Hunninghake","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"R4-5-20210204","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1056\/NEJMra071714","article-title":"Sarcoidosis.","volume":"357","author":"Iannuzzi","year":"2007","journal-title":"N Engl J Med"},{"key":"R5-5-20210204","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/00063198-200209000-00022","article-title":"What is the future of methotrexate in sarcoidosis A study review.","volume":"8","author":"Vucinic","year":"2002","journal-title":"Current Opin Pulm Med"},{"key":"R6-5-20210204","first-page":"149","article-title":"ATSERSWASOG statement on sarcoidosis. American Thoracic SocietyEuropean Respiratory SocietyWorld Association of Sarcoidosis and other Granulomatous Disorders.","volume":"16","author":"Hunninghake","year":"1999","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"R7-5-20210204","first-page":"525","article-title":"Prognostic factors predicting the outcome of sarcoidosis: an analysis of 818 patients.","volume":"52","author":"Neville","year":"1983","journal-title":"Q J Med"},{"key":"R8-5-20210204","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1001\/jama.287.10.1301","article-title":"Corticosteroid therapy in pulmonary sarcoidosis: a systematic review.","volume":"287","author":"Paramothayan","year":"2002","journal-title":"JAMA"},{"key":"R9-5-20210204","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0140-6736(03)12888-7","article-title":"Sarcoidosis.","volume":"361","author":"Baughman","year":"2003","journal-title":"Lancet"},{"key":"R10-5-20210204","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rmed.2007.08.010","article-title":"Treatments for pulmonary sarcoidosis.","volume":"102","author":"Paramothayan","year":"2008","journal-title":"Respir Med"},{"key":"R11-5-20210204","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1164\/rccm.201006-0865CI","article-title":"A concise review of pulmonary sarcoidosis.","volume":"183","author":"Baughman","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"R12-5-20210204","first-page":"76","article-title":"Inhibitors of tumor necrosis factor (TNF) in sarcoidosis: who, what, and how to use them.","volume":"25","author":"Baughman","year":"2008","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"R13-5-20210204","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/MCP.0b013e3283480d36","article-title":"Molecular imaging in sarcoidosis.","volume":"17","author":"Mana","year":"2011","journal-title":"Curr Opin Pulm Med"},{"key":"R14-5-20210204","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s00259-009-1097-x","article-title":"F-18-FDG PET, genotype-corrected ACE and sIL-2R in newly diagnosed sarcoidosis.","volume":"36","author":"Keijsers","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R15-5-20210204","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.rmed.2006.06.025","article-title":"ACE ID-corrected Z-scores to identify normal and elevated ACE activity in sarcoidosis.","volume":"101","author":"Kruit","year":"2007","journal-title":"Respir Med"},{"key":"R16-5-20210204","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1373\/49.9.1510","article-title":"Potential usefulness of inflammatory markers to monitor respiratory functional impairment in sarcoidosis.","volume":"49","author":"Rothkrantz-Kos","year":"2003","journal-title":"Clin Chem"},{"key":"R17-5-20210204","first-page":"158","article-title":"The prognosis of sarcoidosis in Finland and Hokkaido, Japan. A comparative five-year study of biopsy-proven cases.","volume":"17","author":"Pientinalho","year":"2000","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"R18-5-20210204","first-page":"113","article-title":"Angiotensin converting enzyme. Serum levels as monitors of disease activity in corticosteroid-treated sarcoidosis.","volume":"61","author":"Gronhagen-Riska","year":"1980","journal-title":"Eur J Respir Dis"},{"key":"R19-5-20210204","first-page":"631","article-title":"Effects of sarcoid and steroids on angiotensin-converting enzyme.","volume":"128","author":"Baughman","year":"1983","journal-title":"Am Rev Respir Dis"},{"key":"R20-5-20210204","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.clinimag.2007.11.005","article-title":"Use of integrated FDG-PETCT in sarcoidosis.","volume":"32","author":"Kruger","year":"2008","journal-title":"Clin Imaging"},{"key":"R21-5-20210204","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1378\/chest.07-1178","article-title":"Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis.","volume":"132","author":"Teirstein","year":"2007","journal-title":"Chest"},{"key":"R22-5-20210204","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s11307-008-0191-y","article-title":"Early 2-deoxy-2-F-18fluoro-D-glucose PET metabolic response after corticosteroid therapy to differentiate cancer from sarcoidosis and sarcoid-like lesions.","volume":"11","author":"Aide","year":"2009","journal-title":"Mol Imaging Biol"},{"key":"R23-5-20210204","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1007\/s00259-008-0770-9","article-title":"F-18-FDG PETCT in sarcoidosis management: review and report of 20 cases.","volume":"35","author":"Braun","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R24-5-20210204","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/01.rlu.0000252216.68848.d7","article-title":"Value of FDG positron emission tomography in monitoring the effects of therapy in progressive pulmonary sarcoidosis.","volume":"32","author":"Kaira","year":"2007","journal-title":"Clin Nucl Med"},{"key":"R25-5-20210204","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1159\/000072906","article-title":"Fluorodeoxyglucose PET scan in pulmonary sarcoidosis during treatment with inhaled and oral corticosteroids.","volume":"70","author":"Milman","year":"2003","journal-title":"Respiration"},{"key":"R26-5-20210204","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.2967\/jnumed.112.104380","article-title":"The utility of F-18-fluoro-deoxy-glucose PETCT for diagnosis and adjustment of therapy in patients with active chronic sarcoidosis.","volume":"53","author":"Sobic-Saranovic","year":"2012","journal-title":"J Nucl Med"},{"key":"R27-5-20210204","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1148\/rg.242025724","article-title":"An introduction to PET-CT imaging.","volume":"24","author":"Kapoor","year":"2004","journal-title":"Radiographics"},{"key":"R28-5-20210204","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/j.rmed.2011.08.012","article-title":"Inflammatory activity assessment by F-18 FDG-PETCT in persistent symptomatic sarcoidosis.","volume":"105","author":"Mostard","year":"2011","journal-title":"Respir Med"},{"key":"R29-5-20210204","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1055\/s-2007-970332","article-title":"Pathology of sarcoidosis.","volume":"28","author":"Rosen","year":"2007","journal-title":"Semin Respir Crit Care Med"},{"key":"R30-5-20210204","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1378\/chest.74.2.122","article-title":"Nongranulomatous interstitial pneumonitis in sarcoidosis. Relationship to development of epithelioid granulomas.","volume":"74","author":"Rosen","year":"1978","journal-title":"Chest"},{"key":"R32-5-20210204","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/RLU.0b013e3182335f9b","article-title":"F-18 FDG PETCT for detecting bone and bone marrow involvement in sarcoidosis patients.","volume":"37","author":"Mostard","year":"2012","journal-title":"Clin Nucl Med"},{"key":"R33-5-20210204","first-page":"143","article-title":"F-18-FDG PET in sarcoidosis: an observational study in 12 patients treated with infliximab.","volume":"25","author":"Keijsers","year":"2008","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"R34-5-20210204","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ccm.2008.03.012","article-title":"Treatment of sarcoidosis.","volume":"29","author":"Baughman","year":"2008","journal-title":"Clin Chest Med"},{"key":"R35-5-20210204","first-page":"127","article-title":"The relationship between fatigue and clinical parameters in pulmonary sarcoidosis.","volume":"21","author":"De Vries","year":"2004","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"R36-5-20210204","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1164\/ajrccm.164.2.2011009","article-title":"Ace gene ID polymorphism and sarcoidosis pulmonary disease severity.","volume":"164","author":"McGrath","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"R37-5-20210204","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1183\/09031936.94.07030624","article-title":"Consensus conference: activity of sarcoidosis.","volume":"7","author":"Costabel","year":"1994","journal-title":"Eur Respir J"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0b013e31828731f5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T15:29:47Z","timestamp":1621870187000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201307000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0b013e31828731f5","relation":{},"ISSN":["0363-9762"],"issn-type":[{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}